Neural substrate of quality of life in patients with schizophrenia: a magnetisation transfer imaging study

Sci Rep. 2015 Dec 3:5:17650. doi: 10.1038/srep17650.

Abstract

The aim of this study was to investigate the neural substrate underlying quality of life (QoL) and to demonstrate the microstructural abnormalities associated with impaired QoL in a large sample of patients with schizophrenia, using magnetisation transfer imaging. A total of 81 right-handed men with a diagnosis of schizophrenia and 25 age- and sex-similar healthy controls were included and underwent a 3T MRI with magnetization transfer ratio (MTR) to detect microstructural abnormalities. Compared with healthy controls, patients with schizophrenia had grey matter (GM) decreased MTR values in the temporal lobe (BA21, BA37 and BA38), the bilateral insula, the occipital lobe (BA17, BA18 and BA19) and the cerebellum. Patients with impaired QoL had lower GM MTR values relative to patients with preserved QoL in the bilateral temporal pole (BA38), the bilateral insula, the secondary visual cortex (BA18), the vermis and the cerebellum. Significant correlations between MTR values and QoL scores (p < 0.005) were observed in the GM of patients in the right temporal pole (BA38), the bilateral insula, the vermis and the right cerebellum. Our study shows that QoL impairment in patients with schizophrenia is related to the microstructural changes in an extensive network, suggesting that QoL is a bio-psychosocial marker.

Trial registration: ClinicalTrials.gov NCT01295411.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Brain / pathology
  • Brain / ultrastructure*
  • Cerebral Cortex / pathology
  • Cerebral Cortex / ultrastructure
  • Gray Matter / pathology
  • Gray Matter / ultrastructure*
  • Humans
  • Image Processing, Computer-Assisted
  • Magnetic Resonance Imaging*
  • Male
  • Middle Aged
  • Neurons / metabolism
  • Quality of Life
  • Radiography
  • Schizophrenia / diagnostic imaging*
  • Schizophrenia / pathology
  • Surveys and Questionnaires
  • Temporal Lobe / pathology
  • Temporal Lobe / ultrastructure

Associated data

  • ClinicalTrials.gov/NCT01295411